Go Pro

Phreesia (PHR) Competitors

Phreesia logo
$10.26 +0.20 (+1.94%)
Closing price 03:59 PM Eastern
Extended Trading
$10.15 -0.11 (-1.11%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PHR vs. RAMP, ASTH, ATHM, TNET, and HAWK

Should you buy Phreesia stock or one of its competitors? MarketBeat compares Phreesia with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Phreesia include LiveRamp (RAMP), Astrana Health (ASTH), Autohome (ATHM), TriNet Group (TNET), and HawkEye 360 (HAWK). These companies are all part of the "business services" industry.

How does Phreesia compare to LiveRamp?

Phreesia (NYSE:PHR) and LiveRamp (NYSE:RAMP) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends.

In the previous week, Phreesia had 26 more articles in the media than LiveRamp. MarketBeat recorded 27 mentions for Phreesia and 1 mentions for LiveRamp. Phreesia's average media sentiment score of 0.16 beat LiveRamp's score of -0.09 indicating that Phreesia is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Phreesia
4 Very Positive mention(s)
0 Positive mention(s)
21 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
LiveRamp
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Phreesia currently has a consensus price target of $16.65, suggesting a potential upside of 62.17%. LiveRamp has a consensus price target of $40.21, suggesting a potential upside of 7.22%. Given Phreesia's stronger consensus rating and higher possible upside, equities analysts clearly believe Phreesia is more favorable than LiveRamp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Phreesia
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.42
LiveRamp
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Phreesia has a beta of 0.91, meaning that its share price is 9% less volatile than the broader market. Comparatively, LiveRamp has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market.

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 93.8% of LiveRamp shares are owned by institutional investors. 5.2% of Phreesia shares are owned by company insiders. Comparatively, 3.3% of LiveRamp shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

LiveRamp has a net margin of 17.95% compared to Phreesia's net margin of 1.85%. LiveRamp's return on equity of 8.28% beat Phreesia's return on equity.

Company Net Margins Return on Equity Return on Assets
Phreesia1.85% 5.13% 3.12%
LiveRamp 17.95%8.28%6.29%

LiveRamp has higher revenue and earnings than Phreesia. LiveRamp is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phreesia$495.59M1.28$2.31M$0.1568.43
LiveRamp$812.94M2.77$145.95M$2.2816.45

Summary

LiveRamp beats Phreesia on 9 of the 16 factors compared between the two stocks.

How does Phreesia compare to Astrana Health?

Astrana Health (NASDAQ:ASTH) and Phreesia (NYSE:PHR) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Astrana Health has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Astrana Health$3.53B0.71$22.49M$0.6173.82
Phreesia$495.59M1.28$2.31M$0.1568.43

In the previous week, Phreesia had 25 more articles in the media than Astrana Health. MarketBeat recorded 27 mentions for Phreesia and 2 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.94 beat Phreesia's score of 0.16 indicating that Astrana Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Astrana Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Phreesia
4 Very Positive mention(s)
0 Positive mention(s)
21 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Astrana Health has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, Phreesia has a beta of 0.91, meaning that its stock price is 9% less volatile than the broader market.

Astrana Health currently has a consensus price target of $45.00, suggesting a potential downside of 0.07%. Phreesia has a consensus price target of $16.65, suggesting a potential upside of 62.17%. Given Phreesia's higher probable upside, analysts clearly believe Phreesia is more favorable than Astrana Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Phreesia
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.42

Phreesia has a net margin of 1.85% compared to Astrana Health's net margin of 0.86%. Astrana Health's return on equity of 9.22% beat Phreesia's return on equity.

Company Net Margins Return on Equity Return on Assets
Astrana Health0.86% 9.22% 3.54%
Phreesia 1.85%5.13%3.12%

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 92.1% of Phreesia shares are owned by institutional investors. 20.3% of Astrana Health shares are owned by insiders. Comparatively, 5.2% of Phreesia shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Astrana Health beats Phreesia on 10 of the 16 factors compared between the two stocks.

How does Phreesia compare to Autohome?

Phreesia (NYSE:PHR) and Autohome (NYSE:ATHM) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

Phreesia has a beta of 0.91, indicating that its share price is 9% less volatile than the broader market. Comparatively, Autohome has a beta of 0.23, indicating that its share price is 77% less volatile than the broader market.

Autohome has higher revenue and earnings than Phreesia. Autohome is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phreesia$495.59M1.28$2.31M$0.1568.43
Autohome$6.05B0.36$225.19M$1.3114.52

In the previous week, Phreesia had 25 more articles in the media than Autohome. MarketBeat recorded 27 mentions for Phreesia and 2 mentions for Autohome. Autohome's average media sentiment score of 0.29 beat Phreesia's score of 0.16 indicating that Autohome is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Phreesia
4 Very Positive mention(s)
0 Positive mention(s)
21 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Autohome
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Phreesia presently has a consensus target price of $16.65, suggesting a potential upside of 62.17%. Autohome has a consensus target price of $17.15, suggesting a potential downside of 9.81%. Given Phreesia's stronger consensus rating and higher probable upside, research analysts clearly believe Phreesia is more favorable than Autohome.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Phreesia
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.42
Autohome
2 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.60

92.1% of Phreesia shares are held by institutional investors. Comparatively, 63.1% of Autohome shares are held by institutional investors. 5.2% of Phreesia shares are held by insiders. Comparatively, 5.7% of Autohome shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Autohome has a net margin of 17.91% compared to Phreesia's net margin of 1.85%. Phreesia's return on equity of 5.13% beat Autohome's return on equity.

Company Net Margins Return on Equity Return on Assets
Phreesia1.85% 5.13% 3.12%
Autohome 17.91%5.01%4.01%

Summary

Phreesia beats Autohome on 9 of the 16 factors compared between the two stocks.

How does Phreesia compare to TriNet Group?

TriNet Group (NYSE:TNET) and Phreesia (NYSE:PHR) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

TriNet Group has a beta of 1.01, meaning that its share price is 1% more volatile than the broader market. Comparatively, Phreesia has a beta of 0.91, meaning that its share price is 9% less volatile than the broader market.

TriNet Group currently has a consensus target price of $55.80, indicating a potential upside of 9.96%. Phreesia has a consensus target price of $16.65, indicating a potential upside of 62.17%. Given Phreesia's stronger consensus rating and higher probable upside, analysts plainly believe Phreesia is more favorable than TriNet Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriNet Group
2 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.14
Phreesia
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.42

In the previous week, Phreesia had 23 more articles in the media than TriNet Group. MarketBeat recorded 27 mentions for Phreesia and 4 mentions for TriNet Group. TriNet Group's average media sentiment score of 0.69 beat Phreesia's score of 0.16 indicating that TriNet Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TriNet Group
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Phreesia
4 Very Positive mention(s)
0 Positive mention(s)
21 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

TriNet Group has higher revenue and earnings than Phreesia. TriNet Group is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriNet Group$5.01B0.47$155M$3.3515.15
Phreesia$495.59M1.28$2.31M$0.1568.43

96.8% of TriNet Group shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 40.0% of TriNet Group shares are held by company insiders. Comparatively, 5.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

TriNet Group has a net margin of 3.22% compared to Phreesia's net margin of 1.85%. TriNet Group's return on equity of 219.54% beat Phreesia's return on equity.

Company Net Margins Return on Equity Return on Assets
TriNet Group3.22% 219.54% 5.42%
Phreesia 1.85%5.13%3.12%

Summary

TriNet Group beats Phreesia on 11 of the 17 factors compared between the two stocks.

How does Phreesia compare to HawkEye 360?

HawkEye 360 (NYSE:HAWK) and Phreesia (NYSE:PHR) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

HawkEye 360 presently has a consensus price target of $38.38, indicating a potential upside of 75.87%. Phreesia has a consensus price target of $16.65, indicating a potential upside of 62.17%. Given HawkEye 360's stronger consensus rating and higher possible upside, equities analysts plainly believe HawkEye 360 is more favorable than Phreesia.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HawkEye 360
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.89
Phreesia
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.42

Phreesia has a net margin of 1.85% compared to HawkEye 360's net margin of 0.00%. Phreesia's return on equity of 5.13% beat HawkEye 360's return on equity.

Company Net Margins Return on Equity Return on Assets
HawkEye 360N/A N/A N/A
Phreesia 1.85%5.13%3.12%

Phreesia has higher revenue and earnings than HawkEye 360.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HawkEye 360$204.21M10.47N/AN/AN/A
Phreesia$495.59M1.28$2.31M$0.1568.43

In the previous week, Phreesia had 23 more articles in the media than HawkEye 360. MarketBeat recorded 27 mentions for Phreesia and 4 mentions for HawkEye 360. Phreesia's average media sentiment score of 0.16 beat HawkEye 360's score of -0.33 indicating that Phreesia is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HawkEye 360
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Phreesia
4 Very Positive mention(s)
0 Positive mention(s)
21 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

HawkEye 360 has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market. Comparatively, Phreesia has a beta of 0.91, indicating that its stock price is 9% less volatile than the broader market.

90.7% of HawkEye 360 shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 3.8% of HawkEye 360 shares are held by company insiders. Comparatively, 5.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Phreesia beats HawkEye 360 on 11 of the 15 factors compared between the two stocks.

Get Phreesia News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PHR vs. The Competition

MetricPhreesiaMEDICAL INFO SYS IndustryMedical SectorNYSE Exchange
Market Cap$634.50M$1.73B$6.84B$23.41B
Dividend YieldN/AN/A2.67%4.08%
P/E Ratio68.4379.8025.8331.73
Price / Sales1.287.22540.6020.03
Price / Cash13.4924.7329.0918.60
Price / Book1.845.6310.984.78
Net Income$2.31M-$54.76M$3.57B$1.07B
7 Day Performance14.82%5.67%3.05%1.42%
1 Month Performance4.76%-1.63%0.72%0.76%
1 Year Performance-63.92%2.47%36.81%25.45%

Phreesia Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PHR
Phreesia
3.93 of 5 stars
$10.27
+1.9%
$16.65
+62.2%
-65.0%$634.50M$495.59M68.431,789
RAMP
LiveRamp
2.6283 of 5 stars
$37.61
-0.4%
$40.21
+6.9%
+15.2%$2.27B$812.94M16.491,300
ASTH
Astrana Health
2.4091 of 5 stars
$39.59
+1.1%
$45.00
+13.7%
+80.0%$2.18B$3.18B64.903,000
ATHM
Autohome
3.397 of 5 stars
$18.51
+2.3%
$17.15
-7.3%
-28.2%$2.08B$922.63M14.134,242
TNET
TriNet Group
4.0845 of 5 stars
$43.12
-4.8%
$55.20
+28.0%
-31.3%$2.08B$5.01B12.873,400

Related Companies and Tools


This page (NYSE:PHR) was last updated on 6/29/2026 by MarketBeat.com Staff.
From Our Partners